Familial multiple nevi flammei: genes and variants
Explore variant evidence for Familial multiple nevi flammei across 2 analyzed proteins (GNAQ, GNA11). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial multiple nevi flammei
GNAQ: Guanine nucleotide-binding protein G(q) subunit alpha
It links Gq-coupled receptors to phospholipase C signaling and intracellular calcium release. Somatic activating variants are major drivers of uveal melanoma and Sturge-Weber-associated vascular malformations, depending on the developmental timing and cell type affected.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GNAQ have source records linked to Familial multiple nevi flammei. Association strength is not clinical gene validity.
GNA11: Guanine nucleotide-binding protein subunit alpha-11
It transmits signals from Gq-coupled receptors to phospholipase C and downstream calcium and protein-kinase-C pathways. Germline activating variants can cause autosomal dominant hypocalcemia, while somatic activating variants drive uveal melanoma and some vascular lesions.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GNA11 have source records linked to Familial multiple nevi flammei. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Familial multiple nevi flammei
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GNAQ Q209H | 209 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNA11 R183H | 183 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAQ R183G | 183 | G-alpha | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Autosomal dominant hypocalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Familial multiple nevi flammei variants (6 pathogenic / likely pathogenic).
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Familial multiple nevi flammei variants (4 pathogenic / likely pathogenic).
Diseases related to Familial multiple nevi flammei
- Familial hypocalciuric hypercalcemia, also linked to GNA11
- Autosomal dominant hypocalcemia, also linked to GNA11
- Vascular malformation, also linked to GNA11
- Angioosteohypertrophic syndrome, also linked to GNAQ
- Familial hypoparathyroidism, also linked to GNA11
Frequently asked questions
Which genes have records linked to Familial multiple nevi flammei?
This view contains 2 analyzed proteins: GNAQ, GNA11. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 5 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center